SSE Ticker: 600976

Jianmin Pharmaceutical Group Co., Ltd.

健民集团

Authorized Representative: 刘勤强

Board: Main A

Industry Classification: Wholesale & Retail

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Post date May 16, 2022 — 08:44 Post Lock

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value

Post date May 14, 2022 — 13:05 Post Lock

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net

Post date May 14, 2022 — 11:00 Post Lock

Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline

Post date May 13, 2022 — 21:04 Post Lock

Industry mergers and acquisitions increase, shell transactions are cold, and the A-share market breaks the "shell" and establishes a "industry"

Post date May 12, 2022 — 05:24 Post Lock

The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached)

Post date May 11, 2022 — 20:43 Post Lock

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

Post date May 10, 2022 — 10:07 Post Lock

China Resources 392.9 billion won the controlling stake of Kunming Pharmaceutical Group

Post date May 10, 2022 — 00:12 Post Lock

China Resources 392.9 billion won the controlling stake of Kunming Pharmaceutical Group

Post date May 10, 2022 — 00:04 Post Lock

"Huali Department" exit: China Resources Sanjiu plans to take charge of Kunming Pharmaceutical Group with 2.902 billion yuan before the suspension of trading. Kunming Pharmaceutical Group

Post date May 9, 2022 — 22:22 Post Lock

"Huali Department" withdrew, China Resources Sanjiu planned to take charge of Kunming Pharmaceutical Group with 2.902 billion yuan, and before the suspension of trading, there was a high volume limit – yqqlm

Post date May 9, 2022 — 21:28 Post Lock

The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan.

Post date May 9, 2022 — 18:53 Post Lock

20220507 famous sayings

Post date May 7, 2022 — 18:50 Post Lock

Qianhai Kaiyuan Traditional Chinese Medicine Research Selected Stocks Initiated A Net Value Up 3.08% Qianhai Kaiyuan_Sina Finance_Sina Network

Post date May 6, 2022 — 09:00 Post Lock

Qianhai Kaiyuan Traditional Chinese Medicine Research Selected Stocks Initiated C Net Value Up 3.08% Qianhai Kaiyuan_Sina Finance_Sina.com

Post date May 6, 2022 — 09:00 Post Lock

Galaxy Recreation's net worth rose 3.53% Galaxy_Sina Finance_Sina.com

Post date May 6, 2022 — 08:57 Post Lock

Trends of the main institutions in the first quarter: the "ace portfolio" of the social security fund insists on growth; the pension fund grabs 47 shares!

Post date May 5, 2022 — 08:35 Post Lock

Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball

Post date May 3, 2022 — 18:04 Post Lock

The operation of insurance capital in the first quarter was "frustrated", and nearly 90% of the heavily held stocks underperformed the market Rongyi Industry Rongyi Information Network

Post date May 3, 2022 — 14:42 Post Lock

What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code)

Post date May 2, 2022 — 11:17 Post Lock

Want to see more data? Registered subscribers can see all the data.